|
|
||||||||
Technical Developments |
1 From the Departments of Epidemiology & Biostatistics (M.W.V., M.A.I., M.M.B.B.) and Radiology (M.W.V., P.A.W., G.P.K., A.v.d.L.), Erasmus MC University Medical Center, 's-Gravendijkwal 230, 3015 CE Rotterdam, the Netherlands. Received July 3, 2007; revision requested September 3; revision received September 25; final version accepted February 1, 2008. Address correspondence to A.v.d.L. (e-mail: a.vanderlugt@erasmusmc.nl).
The purpose of this study was to prospectively compare high-spatial-resolution accelerated three-dimensional (3D) T2*-weighted gradient-recalled-echo (GRE) magnetic resonance (MR) images with conventional two-dimensional (2D) T2*-weighted GRE MR images for the depiction of cerebral microbleeds. After obtaining institutional review board approval and informed consent, 200 elderly participants (age range, 69.7–96.7 years; 108 [54%] women) were imaged at 1.5 T by using both sequences. Presence, number, and location of microbleeds were recorded for both sequences, and differences were tested by using McNemar and signed rank tests. Cerebral microbleeds were detected in significantly more participants on 3D T2*-weighted GRE images (35.5%) than on 2D T2*-weighted GRE images (21.0%; P < .001). Furthermore, in persons with microbleeds visualized on both image sets, significantly more microbleeds (P < .001) were seen on 3D images than on 2D images. For both sequences, the proportion of participants with a microbleed in a lobar (cortical gray and subcortical white matter), deep, or infratentorial location was similar. In conclusion, accelerated 3D T2*-weighted GRE images depict more microbleeds than do conventional 2D T2*-weighted GRE images.
© RSNA, 2008
This article has been cited by other articles:
![]() |
M. W. Vernooij, M. D. M. Haag, A. van der Lugt, A. Hofman, G. P. Krestin, B. H. Stricker, and M. M. B. Breteler Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study Arch Neurol, June 1, 2009; 66(6): 714 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Luo, K. Numata, M. Morimoto, M. Kondo, S. Takebayashi, M. Okada, S. Morita, and K. Tanaka Focal Liver Tumors: Characterization with 3D Perflubutane Microbubble Contrast Agent-enhanced US versus 3D Contrast-enhanced Multidetector CT Radiology, April 1, 2009; 251(1): 287 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.N.K. Nandigam, A. Viswanathan, P. Delgado, M.E. Skehan, E.E. Smith, J. Rosand, S.M. Greenberg, and B.C. Dickerson MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 338 - 343. [Abstract] [Full Text] [PDF] |
||||